Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Tammenoms Bakker Juliet
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-04-19
Purchase
2022-04-21
6:04 pm
Inozyme Pharma Inc. INZY Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
1,355,000 $3.69 $4,999,950 4,174,379
(Indirect)
View
2022-02-10
Purchase
2022-04-05
07:24 am
Vera Therapeutics Inc. VERA Longitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
10% Owner
333,333 $15 $4,999,995 3,429,927
(Indirect)
View
2022-02-02
Purchase
2022-02-02
9:25 pm
Sierra Oncology Inc. SRRA Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
Longitude Prime Partners LLC
Longitude Prime Fund L.P.
10% Owner
175,000 $27 $4,725,000 2,139,771
(Indirect)
View
2021-08-03
Purchase
2021-08-05
7:41 pm
RxSight Inc. RXST Tammenoms Bakker Juliet
Director
637,500 $16 $10,200,000 562,838
(Indirect
Direct)
View
2021-07-19
Purchase
2021-07-20
9:39 pm
RAPID MICRO BIOSYSTEMS Inc RPID Longitude Capital Partners II LLC
Longitude Venture Partners II L.P.
Longitude Prime Partners LLC
Longitude Prime Fund L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
150,000 $20 $3,000,000 779,032
(Indirect)
View
2021-05-18
Purchase
2021-05-18
8:20 pm
Vera Therapeutics Inc. VERA Longitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
10% Owner
909,090 $11 $9,999,990 3,096,594
(Indirect)
View
2021-05-11
Purchase
2021-05-11
8:29 pm
Talaris Therapeutics Inc. TALS Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
235,000 $17 $3,995,000 3,220,775
(Indirect)
View
2020-10-20
Purchase
2020-10-22
7:53 pm
Eargo Inc. EAR Tammenoms Bakker Juliet
Director
10% Owner
233,333 $18 $4,199,994 3,918,691
(Indirect)
View
2020-09-18
Sale
2020-09-22
6:01 pm
Axonics Modulation Technologies Inc. AXNX Tammenoms Bakker Juliet
Director
9,167 $42.67 $391,119 1,959,859
(Indirect
Direct)
View
2020-08-28
Sale
2020-09-01
7:33 pm
Molecular Templates Inc. MTEM Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
3,496 $10.75 $37,568 3,202,530
(Indirect)
View
2020-08-14
Sale
2020-08-18
5:32 pm
Axonics Modulation Technologies Inc. AXNX Tammenoms Bakker Juliet
Director
2,393 $43.22 $103,422 1,965,526
(Indirect
Direct)
View
2020-07-28
Purchase
2020-07-28
6:20 pm
Inozyme Pharma Inc. INZY Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
625,000 $16 $10,000,000 2,819,379
(Indirect)
View
2020-07-10
Purchase
2020-07-14
8:11 pm
89bio Inc. ETNB Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
109,090 $27.5 $2,999,975 2,600,877
(Indirect)
View
2019-11-25
Purchase(A)
2019-12-05
4:16 pm
Molecular Templates Inc. MTEM Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
937,500 $8 $7,500,000 4,199,035
(Indirect)
View
2019-11-25
Purchase
2019-11-27
4:47 pm
Molecular Templates Inc. MTEM Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
937,000 $8 $7,496,000 4,198,535
(Indirect)
View
2019-11-11
Purchase
2019-11-13
7:02 pm
89bio Inc. ETNB Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
575,000 $16 $9,200,000 2,491,787
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-04-27
Other
2022-04-29
7:07 pm
N/A
N/A
Sierra Oncology Inc. SRRA Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
Longitude Prime Partners LLC
Longitude Prime Fund L.P.
10% Owner
2,155,801 $0 2,163,816
(Indirect)
View
2022-01-25
Exercise
2022-01-27
9:23 pm
2020-01-22
2022-04-10
Sierra Oncology Inc. SRRA Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
1,964,576 $13.2 1,964,771
(Indirect)
View
2021-08-03
Conversion
2021-08-05
7:41 pm
N/A
N/A
RxSight Inc. RXST Tammenoms Bakker Juliet
Director
3,727,226 $0 562,838
(Indirect)
View
2021-08-03
Tax Withholding
2021-08-05
7:41 pm
N/A
N/A
RxSight Inc. RXST Tammenoms Bakker Juliet
Director
28,125 $0 562,838
(Indirect)
View
2021-08-03
Exercise
2021-08-05
7:41 pm
2017-02-24
N/A
RxSight Inc. RXST Tammenoms Bakker Juliet
Director
72,604 $0 562,838
(Indirect)
View
2021-07-30
Option Award
2021-08-02
8:17 pm
N/A
N/A
RxSight Inc. RXST Tammenoms Bakker Juliet
Director
5,859 $0 5,859
(Direct)
View
2021-07-29
Ownership
2021-07-29
10:42 am
N/A
N/A
RxSight Inc. RXST Tammenoms Bakker Juliet
Director
0 $0 1,891,738
(Indirect)
View
2021-07-19
Conversion
2021-07-20
9:39 pm
N/A
N/A
RAPID MICRO BIOSYSTEMS Inc RPID Longitude Capital Partners II LLC
Longitude Venture Partners II L.P.
Longitude Prime Partners LLC
Longitude Prime Fund L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
23,838,431 $0 779,032
(Indirect)
View
2021-07-14
Ownership
2021-07-14
7:35 pm
N/A
N/A
RAPID MICRO BIOSYSTEMS Inc RPID Longitude Capital Partners II LLC
Longitude Venture Partners II L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
0 $0 6,558,675
(Indirect)
View
2021-05-17
Other
2021-05-19
4:58 pm
N/A
N/A
Eargo Inc. EAR Tammenoms Bakker Juliet
Director
10% Owner
1,005,012 $0 1,015,036
(Indirect)
View
2021-05-18
Conversion
2021-05-18
8:20 pm
N/A
N/A
Vera Therapeutics Inc. VERA Longitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
10% Owner
2,187,504 $0 3,096,594
(Indirect)
View
2021-05-13
Ownership
2021-05-13
7:27 pm
N/A
N/A
Vera Therapeutics Inc. VERA Longitude Capital Partners IV LLC
Longitude Venture Partners IV L.P.
Tammenoms Bakker Juliet
10% Owner
0 $0 2,187,504
(Indirect)
View
2021-05-11
Conversion
2021-05-11
8:29 pm
N/A
N/A
Talaris Therapeutics Inc. TALS Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
5,971,550 $0 3,220,775
(Indirect)
View
2021-05-06
Ownership
2021-05-06
9:25 pm
N/A
N/A
Talaris Therapeutics Inc. TALS Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
0 $0 2,985,775
(Indirect)
View
2021-04-14
Other
2021-04-15
9:04 pm
N/A
N/A
Eargo Inc. EAR Tammenoms Bakker Juliet
Director
10% Owner
1,005,012 $0 1,010,024
(Indirect)
View
2020-11-16
Other
2020-11-18
7:11 pm
N/A
N/A
89bio Inc. ETNB Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
855,944 $0 856,835
(Indirect)
View
2020-10-20
Conversion
2020-10-22
7:53 pm
N/A
N/A
Eargo Inc. EAR Tammenoms Bakker Juliet
Director
10% Owner
3,685,358 $0 3,918,691
(Indirect)
View
2020-10-15
Option Award
2020-10-19
6:07 pm
N/A
2030-10-14
Eargo Inc. EAR Tammenoms Bakker Juliet
Director
10% Owner
6,666 $0 6,666
(Direct)
View
2020-10-15
Ownership
2020-10-15
8:18 pm
N/A
N/A
Eargo Inc. EAR Tammenoms Bakker Juliet
Director
10% Owner
0 $0 3,685,358
(Indirect)
View
2020-08-24
Option Award
2020-08-26
8:17 pm
N/A
N/A
Axonics Modulation Technologies Inc. AXNX Tammenoms Bakker Juliet
Director
3,500 $0 1,969,026
(Direct)
View
2020-08-10
Other
2020-08-12
8:10 pm
N/A
N/A
Axonics Modulation Technologies Inc. AXNX Tammenoms Bakker Juliet
Director
981,419 $0 994,005
(Indirect)
View
2020-07-28
Conversion
2020-07-28
6:20 pm
N/A
N/A
Inozyme Pharma Inc. INZY Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
18,592,979 $0 2,819,379
(Indirect)
View
2020-07-23
Ownership
2020-07-23
9:26 pm
N/A
N/A
Inozyme Pharma Inc. INZY Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
0 $0 2,194,379
(Indirect)
View
2020-06-11
Ownership
2020-06-11
7:56 pm
N/A
N/A
Vaxcyte Inc. PCVX Longitude Capital Partners II LLC
Longitude Venture Partners II L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
0 $0 3,606,350
(Indirect)
View
2020-05-26
Other
2020-05-28
9:07 pm
N/A
N/A
Molecular Templates Inc. MTEM Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
ENRIGHT PATRICK G
Tammenoms Bakker Juliet
10% Owner
1,006,991 $0 1,008,040
(Indirect)
View
2020-01-29
Conversion
2020-01-31
5:45 pm
N/A
N/A
Sierra Oncology Inc. SRRA Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
1,496,820 $0 1,477,320
(Indirect)
View
2019-11-22
Ownership
2019-11-26
8:56 pm
N/A
N/A
Sierra Oncology Inc. SRRA Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
0 $0 137,668,050
(Indirect)
View
2019-11-11
Conversion
2019-11-13
7:02 pm
N/A
N/A
89bio Inc. ETNB Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
13,833,454 $0 2,491,787
(Indirect)
View
2019-11-08
Ownership
2019-11-08
7:21 pm
N/A
N/A
89bio Inc. ETNB Longitude Capital Partners III LLC
Longitude Venture Partners III L.P.
Tammenoms Bakker Juliet
ENRIGHT PATRICK G
10% Owner
0 $0 1,916,787
(Indirect)
View
2019-11-07
Option Award
2019-11-07
9:51 pm
N/A
2027-03-06
Venus Concept Inc. VERO Tammenoms Bakker Juliet
Director
10% Owner
3,692,070 $0 3,692,070
(Direct)
View
2019-08-22
Option Award
2019-08-26
6:58 pm
N/A
2029-08-22
Axonics Modulation Technologies Inc. AXNX Tammenoms Bakker Juliet
Director
10% Owner
15,000 $0 2,952,500
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, Next